A 56 year-old male comes to your office for the management of his very high LDL levels. He has been taking a statin for a few years but his LDL levels have not come down to a desired level. You decided to add a fibrate to his treatment regimen. Of the following, which is the most concerning adverse effect to be monitored when you add a fibrate to a statin?